A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
NCT01700036
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Graft vs Host Disease
Interventions
DRUG:
Alpha-1-Antitrypsin (AAT)
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
[object Object]
[object Object]